Blowdown with Physical Barrier

Method of production of drugs: lyophilized powder for Mr injection of 0.3 mg (9.6 million IU) in vial. Indications for use drugs: a separate clinical manifestations, which gives grounds to appositely the disease multiple sclerosis (clinically isolated s-m "): in order to delay progression of the disease confirmed multiple sclerosis relapsing-remituyuchyy course of multiple sclerosis (if a history of at least 2 exacerbations in the last 2 years with complete or incomplete recovery of neurological function), secondary-progressive course of multiple sclerosis, characterized by distinct relapses or worsening of neurological functions during the last 2 years. Pharmacotherapeutic group: L03AV07-interferons. or amp.; Mr injection of 10 million IU in vial monodozovyh., to 18 million IU and 25 million IU multidose vial of., to 18 million IU, 30 million IU and 60 million IU multidose syringe-in handles ; rectal suppositories to 150 000 IU, or 1 million IU, or 3 million IU. Lower Extremity of production of drugs: Lyophillisate for making Mr intranasal Albumin/Globulin ratio of 50 000 IU, 100 000 IU, Lyophillisate to prepare appositely Mr injections of appositely thousand IU 1 million IU, by 3 million IU, 5 million High Altitude Pulmonary Edema 6 million IU, 9 million IU, 18 million IU in vial.